CD8A and renal cell adenocarcinoma: We demonstrated that patients who progressed to metastatic disease had smaller distances between CD8+ T cells and RCC cells (mean distance of 20.72 μm for patients who progressed versus that of 15.92 μm for patients who did not progress, p = 0.03; Figure 6C).